Oncology Institute, Inc. (TOI) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Oncology Institute, Inc.'s filing signal continuing positive.

The Oncology Institute, Inc. (TOI) is a national leader in value-based oncology care, aiming to reduce costs while maintaining high clinical standards. Operating through 65 clinics across five states and a network of 81 independent clinics and 198 independent providers, TOI manages care for approximately 2.0 million patients under value-based agreements as of December 31, 2025. The company's model focuses on partnerships with managed care providers and risk-bearing entities, utilizing gain/loss sharing and capitation contracts to manage patient populations. TOI also offers specialty pharmacy services and manages clinical trials through its research arm. Its strategy emphasizes growth through existing market expansion, new market entry, and potential acquisitions, all while prioritizing patient-centric, evidence-based care.

Revenue is primarily driven by capitation fees from managed care organizations and fee-for-service payments for medical services. Additional revenue streams include specialty pharmacy sales and clinical trial services.